BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Deng X, Allan-Blitz LT, Klausner JD. Using the genetic characteristics of Neisseria gonorrhoeae strains with decreased susceptibility to cefixime to develop a molecular assay to predict cefixime susceptibility. Sex Health 2019;16:488-99. [PMID: 31230613 DOI: 10.1071/SH18227] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Palace SG, Wang Y, Rubin DH, Welsh MA, Mortimer TD, Cole K, Eyre DW, Walker S, Grad YH. RNA polymerase mutations cause cephalosporin resistance in clinical Neisseria gonorrhoeae isolates. Elife 2020;9:e51407. [PMID: 32011233 DOI: 10.7554/eLife.51407] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
2 Golparian D, Unemo M. Antimicrobial resistance prediction in Neisseria gonorrhoeae: Current status and future prospects. Expert Rev Mol Diagn 2021. [PMID: 34872437 DOI: 10.1080/14737159.2022.2015329] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
3 Thomas JC, Kersh EN, Gernert KM, Shafer WM, Raphael BH. Reply: Evidence of Recent Genomic Evolution in Gonococcal Strains With Decreased Susceptibility to Cephalosporins or Azithromycin in the United States, 2014-2016. J Infect Dis 2020;221:852-3. [PMID: 31581287 DOI: 10.1093/infdis/jiz505] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Lin EY, Adamson PC, Deng X, Klausner JD. Establishing Novel Molecular Algorithms to Predict Decreased Susceptibility to Ceftriaxone in Neisseria gonorrhoeae Strains. J Infect Dis 2021;223:1232-40. [PMID: 32779717 DOI: 10.1093/infdis/jiaa495] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Deng X, Klausner JD. Six penA Codons Accurately and Reliably Predict Cefixime-Decreased Susceptibility in Neisseria gonorrhoeae. J Infect Dis 2020;221:851-2. [PMID: 31581294 DOI: 10.1093/infdis/jiz504] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Lin EY, Adamson PC, Klausner JD. Epidemiology, Treatments, and Vaccine Development for Antimicrobial-Resistant Neisseria gonorrhoeae: Current Strategies and Future Directions. Drugs 2021;81:1153-69. [PMID: 34097283 DOI: 10.1007/s40265-021-01530-0] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
7 Allan-Blitz LT, Adamson PC, Klausner JD. Resistance-Guided Therapy for Neisseria gonorrhoeae. Clin Infect Dis 2022:ciac371. [PMID: 35818315 DOI: 10.1093/cid/ciac371] [Reference Citation Analysis]